Q3 2023 |
252 |
$515M |
+$9.74M |
-$50.8M |
-$41M |
AAPL, MSFT, IVV, VTI, XOM
|
13F-HR |
10/19/2023, 03:00 PM |
Q2 2023 |
274 |
$603M |
+$34.5M |
-$7.05M |
+$27.5M |
AAPL, MSFT, IVV, VTI, XOM
|
13F-HR |
8/7/2023, 06:03 PM |
Q1 2023 |
260 |
$553M |
+$14.5M |
-$41.4M |
-$26.9M |
MSFT, AAPL, IVV, VTI, XOM
|
13F-HR |
5/8/2023, 02:12 PM |
Q4 2022 |
268 |
$556M |
+$72.1M |
-$26M |
+$46.1M |
VUG, MSFT, AAPL, IVV, VTI
|
13F-HR |
2/6/2023, 04:12 PM |
Q3 2022 |
254 |
$476M |
+$50.9M |
-$7.04M |
+$43.9M |
MSFT, AAPL, IVV, VTI, XOM
|
13F-HR |
11/1/2022, 01:52 PM |
Q2 2022 |
266 |
$486M |
+$26.8M |
-$12.4M |
+$14.4M |
MSFT, AAPL, IVV, VTI, JNJ
|
13F-HR |
8/10/2022, 02:55 PM |
Q1 2022 |
288 |
$583M |
+$84.2M |
-$33.1M |
+$51.1M |
MSFT, AAPL, IVV, AMZN, VTI
|
13F-HR |
5/4/2022, 10:34 AM |
Q4 2021 |
269 |
$568M |
+$35.3M |
-$106M |
-$70.4M |
AAPL, MSFT, IVV, AMZN, VTI
|
13F-HR |
2/10/2022, 03:40 PM |
Q3 2021 |
275 |
$624M |
+$17.4M |
-$62.3M |
-$44.9M |
MRNA, MSFT, AAPL, IVV, AMZN
|
13F-HR |
11/4/2021, 07:09 PM |
Q2 2021 |
267 |
$632M |
+$33.1M |
-$5.49M |
+$27.6M |
MRNA, MSFT, AAPL, IVV, AMZN
|
13F-HR |
8/4/2021, 12:36 PM |
Q1 2021 |
243 |
$569M |
+$41.8M |
-$245M |
-$204M |
MRNA, MSFT, AAPL, IVV, AMZN
|
13F-HR |
5/12/2021, 09:10 AM |
Q4 2020 |
709 |
$645M |
+$58.7M |
-$17.2M |
+$41.5M |
MRNA, MSFT, AAPL, IVV, AMZN
|
13F-HR |
2/5/2021, 12:43 PM |
Q3 2020 |
587 |
$514M |
+$34.6M |
-$29M |
+$5.66M |
MRNA, MSFT, AAPL, IVV, AMZN
|
13F-HR |
10/16/2020, 05:14 PM |
Q2 2020 |
543 |
$490M |
+$23.3M |
-$70M |
-$46.7M |
MRNA, MSFT, AAPL, IVV, AMZN
|
13F-HR |
7/20/2020, 10:26 AM |
Q1 2020 |
512 |
$395M |
+$23.4M |
-$55M |
-$31.6M |
MRNA, MSFT, AAPL, IVV, AMZN
|
13F-HR |
4/24/2020, 08:13 AM |
Q4 2019 |
521 |
$463M |
+$22M |
-$72M |
-$50M |
MRNA, MSFT, AAPL, JPM, XOM
|
13F-HR |
2/5/2020, 11:23 AM |
Q3 2019 |
538 |
$471M |
+$14M |
-$26.1M |
-$12.1M |
MRNA, MSFT, AAPL, JPM, XOM
|
13F-HR |
11/5/2019, 12:29 PM |
Q2 2019 |
552 |
$474M |
+$103M |
-$13.1M |
+$89.8M |
MRNA, MSFT, AAPL, XOM, JPM
|
13F-HR |
7/31/2019, 02:39 PM |
Q1 2019 |
503 |
$378M |
+$8.41M |
-$17.9M |
-$9.51M |
MSFT, XOM, AAPL, JNJ, JPM
|
13F-HR |
4/15/2019, 11:11 AM |
Q4 2018 |
490 |
$347M |
+$19.7M |
-$16.4M |
+$3.39M |
MSFT, EFA, XOM, AAPL, JNJ
|
13F-HR |
2/8/2019, 01:48 PM |
Q3 2018 |
516 |
$405M |
+$23.7M |
-$11.2M |
+$12.5M |
MSFT, AAPL, XOM, JNJ, JPM
|
13F-HR |
10/30/2018, 04:10 PM |
Q2 2018 |
549 |
$370M |
+$12.2M |
-$9.87M |
+$2.33M |
XOM, AAPL, MSFT, EFA, JNJ
|
13F-HR |
8/10/2018, 06:00 PM |
Q1 2018 |
560 |
$365M |
+$6.37M |
-$10.4M |
-$4.07M |
XOM, MSFT, AAPL, EFA, JNJ
|
13F-HR |
4/30/2018, 11:43 AM |
Q4 2017 |
754 |
$382M |
+$14.3M |
-$17.3M |
-$2.96M |
XOM, JNJ, AAPL, EFA, MSFT
|
13F-HR |
2/13/2018, 01:02 PM |
Q3 2017 |
684 |
$369M |
+$20.2M |
-$8.45M |
+$11.8M |
XOM, EFA, JNJ, AAPL, MSFT
|
13F-HR |
11/9/2017, 02:13 PM |
Q2 2017 |
504 |
$353M |
+$17.7M |
-$11.7M |
+$6.05M |
XOM, EFA, JNJ, GEXXXX, AAPL
|
13F-HR |
8/11/2017, 04:42 PM |
Q1 2017 |
495 |
$346M |
+$28.5M |
-$11.5M |
+$17M |
XOM, GEXXXX, EFA, JNJ, MSFT
|
13F-HR |
5/4/2017, 04:24 PM |
Q4 2016 |
482 |
$319M |
+$20.3M |
-$3.38M |
+$16.9M |
XOM, GEXXXX, EFA, JNJ, JPM
|
13F-HR |
1/6/2017, 10:29 AM |
Q3 2016 |
447 |
$296M |
+$18.3M |
-$7.8M |
+$10.5M |
XOM, EFA, GEXXXX, JNJ, IBM
|
13F-HR |
11/10/2016, 09:45 AM |
Q2 2016 |
461 |
$287M |
+$58.8M |
-$5.29M |
+$53.5M |
XOM, GEXXXX, EFA, JNJ, IBM
|
13F-HR |
8/8/2016, 04:41 PM |
Q1 2016 |
420 |
$226M |
+$7.8M |
-$8.38M |
-$578K |
EFA, XOM, GEXXXX, IBM, MSFT
|
13F-HR |
5/12/2016, 10:37 AM |
Q4 2015 |
424 |
$227M |
+$32.4M |
-$2.64M |
+$29.8M |
EFA, XOM, GEXXXX, MSFT, IBM
|
Restatement |
5/19/2016, 12:33 PM |
Q3 2015 |
390 |
$191M |
+$27.6M |
-$5.1M |
+$22.5M |
EFA, XOM, GEXXXX, IBM, JNJ
|
Restatement |
5/19/2016, 12:09 PM |
Q2 2015 |
300 |
$184M |
+$2.44M |
-$6.63M |
-$4.19M |
EFA, XOM, GEXXXX, IBM, PFE
|
13F-HR |
8/13/2015, 02:47 PM |
Q1 2015 |
307 |
$193M |
|
|
|
EFA, XOM, GEXXXX, IBM, CNI
|
13F-HR |
5/12/2015, 02:56 PM |